Abstract
Recent clinical studies with adult polytrauma patients indicate that elevated plasma levels of anaphylatoxin C3a correlate with the subsequent development of the adult respiratory distress syndrome (ARDS). However, there are no parameters which allow a reliable diagnosis of ARDS in neonates. As the most predisposing condition for ARDS seems to be shock, plasma C3a was determined in 30 ventilated premature infants and neonates with respiratory distress syndrome (birth weights 660–3350 g) within the first 24 h post partum or 6–24 h after acute asphyxia or shock during the neonatal period. The range of C3a, measured by ELISA, was between 57 and 1000 ng/ml. In the asphyxia group (n=15) peak levels of C3a in plasma (mean 388 ng/ml) were significantly higher (P<0.001) than in the control group (mean 153 ng/ml). In some neonates with suspected ARDS, additional samples were taken. A rise in C3a between days 2 and 8 was associated with a fatal outcome of the disease. As in adults, C3a might be a useful indicator for ARDS in neonates.
Similar content being viewed by others
Abbreviations
- ARDS:
-
adult or acquired respiratory distress syndrome
- IRDS:
-
idiopathic or infantile respiratory distress syndrome
- RDS:
-
respiratory distress syndrome
References
Bland RD (1987) Pathogenesis of pulmonary edema after premature birth. Adv Pediatr 34:175–222
Borelli E, Giomerelli P, Chiari O, Casini A, Betti S, Sabatini L, Lorenzini L, Grossi A (1990) Lipid peroxidation and lung ultrastructural changes in an experimental model of leukocytemediated pulmonary injury. Lung 168:35–42
Burger R, Zilow G, Bader A, Friedlein A, Naser W (1988) The C terminus of the anaphylatoxin C3a generated upon complement activation represents a neoantigenic determinant with diagnostic potential. J Immunol 141:553–558
Drew JH, Arroyave CM (1980) The complement system of the newborn infant. Biol Neonate 37:209–217
Faix RG, Viscardi RM, DiPietro MA, Nicks JJ (1989) Adult respiratory distress syndrome in full-term newborns. Pediatrics 83:971–976
Feinstein PA, Kaplan SR (1975) The alternative pathway of complement activation in the neonate. Pediatr Res 9:803–806
Giedion A, Haeflinger H, Dangel P (1973) Acute pulmonary x-ray changes in hyaline membrane disease treated with artificial ventilation and positive endexpiratory pressure. Pediatr Radiol 1:145–149
Guillois B, Berthou C, Awad H, Bendaoud B, Guillemin G, Alix D, Youinou P (1989) The importance of C3d estimation in the diagnosis of generalized bacterial infections in the newborn infants. Acta Paediatr Scand 78:369–372
Hack CE, Nuijens JH, Felt-Bersma RJ, Schreuder WO, Eerenberg-Belmer AJ, Paardekooper J, Bronsveld W, Thijs LG (1989) Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis. Am J Med 86:20–26
Hammerschmidt DE, Weaver LJ, Hudson LD, Craddock PR, Jacob HS (1980) Association of complement activation and elevated plasma-C5a with adult respiratory distress syndrome. Lancet I:947–949
Hohn DC, Meyers AJ, Gherini ST, Beckmann A, Markison RE, Churg AM (1980) Production of acute pulmonary injury by leukocytes and activated complement. Surgery 88:48–58
Johnston RB, Altenburger KM, Atkinson AW, Curry RH (1979) Complement in the newborn infant. Pediatrics 64 [Suppl]: 781–786
Killermann W, Frentzel-Beyme R, Welte M, Jochum M (1989) Phospholipase A2 in acute lung injury after trauma and sepsis: its relation to the inflammatory mediators PMN-elastase, C3a and neopterin. Klin Wochenschr 67:190–195
Kitajima H, Fujimura M, Takeuchi T, Miyano A, Nakayama M, Fujita T, Imai S, Shimizu A (1990) Effect of amnionitis on the complement system of premature infants. Early Hum Dev 21:59–69
Lambris JD (1988) The multifunctional role of C3, the third component of complement. Immunol Today 9:387–393
Langlois PF, Gawryl MS, Zeller J, Lint T (1989) Accentuated complement activation in patient plasma during the adult respiratory distress syndrome: a potential mechanism for pulmonary inflammation. Heart Lung 18:71–84
Lundberg C, Gardinali M, Hugli TE (1987) Complement activation and membrane lipids in lung vascular injury. Am Rev Respir Dis 136:459–462b
Lyrene RK, Truog WE (1981) Adult respiratory distress syndrome in a pediatric intensive care unit: predisposing conditions, clinical course, and outcome. Pediatrics 67:790–795
Matthay M, Eschenbacher W, Goetzel E (1984) Elevated concentrations of leukotriene B4 in the pulmonary edema fluid of patients with adult respiratory distress syndrome. J Clin Immunol 4:479–483
Modig J, Samuelsson T, Hallgren R (1986) The predictive and discriminative value of biologically active products of eosinophils, neutrophils and complement in bronchoalveolar lavage and blood in patients with adult respiratory distress syndrome. Resuscitation 14:121–134
Notarangelo LD, Chirico G, Chiara A, Colombo A, Rondini G, Plebani A, Martini A, Ugazio AG (1984) Activity of classical and alternative pathways of complement in preterm and small for gestational age infants. Pediatr Res 18:281–285
Parson PE, Worthen GS, Moore EE, Tate RM, Henson PM (1989) The association of circulating endotoxin with the development of the adult respiratory distress syndrome. Am Rev Respir Dis 140:294–301
Pfenninger J, Gerber A, Tschäppeler H, Zimmermann A (1982) Adult respiratory distress syndrome in children. J Pediatr 101:352–357
Rinaldo JE, Rogers RM (1986) Adult respiratory distress syndrome. N Engl J Med 315:578–579
Royall JA, Levin DL (1988) Adult respiratory distress syndrome in pediatric patients. I. Clinical aspects, pathophysiology, pathology, and mechanisms of lung injury. J Pediatr 112: 169–180
Sawyer MK, Forman ML, Kuplic LS, Stiehm ER (1971) Development aspects of the human complement system. Biol Neonate 19:148–162
Shapiro R, Beatty DW, Woods DL, Malan AF, Med M (1981) Serum complement and immunoglobulin values in small-for-gestational-age infants. J Pediatr 99:139–141
Slotman GJ, Burchard KW, Yellin SA, Williams JJ (1986) Prostaglandin and complement interaction in clinical acute respiratory failure. Arch Surg 121:271–274
Strunk RC, Fenton LJ, Gaines JA (1979) Alternative pathway of complement activation in full term and premature infants. Pediatr Res 13:641–643
Thibeault DW, Hall FK, Sheehan MB, et al. (1984) Postasphyxial lung disease in newborn infants with severe perinatal acidosis. Am J Obstet Gynecol 150:393–399
Truog WE, Gibson RL, Henderson WR, Redding GJ (1990) Tumor necrosis factor-induced neonatal pulmonary hypertension: effects of Dazmegrel pretreatment. Pediatr Res 27:466–471
Weigelt JA, Chenoweth DE, Borman KR, Norcross JF (1988) Complement and the severity of pulmonary failure. J Trauma 28:1013–1019
Weinberg PF, Matthay MA, Webster RO, Roskos KV, Goldstein IM, Murray JF (1984) Biologically active products of complement and acute lung injury in patients with sepsis syndrome. Am Rev Respir Dis 130:791–796
Zilow G, Sturm JA, Rother U, Kirschfink M (1990) Complement activation and the prognostic value of C3a in patients at risk of adult respiratory distress syndrome. Clin Exp Immunol 79:151–157
Zilow G, Burger R, Stuthe M, Zilow EP (1990) Increased C3a-des Arg concentration as indicator for neonatal infections. Immunobiology 181:250(A)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schrod, L., Frauendienst-Egger, G., von Stockhausen, H.B. et al. Complement fragment C3a in plasma of asphyxiated neonates. Eur J Pediatr 151, 688–692 (1992). https://doi.org/10.1007/BF01957575
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01957575